Direct comparison
MTA vs. NDA: What Each One Covers
MTA vs. NDA compared: scope, duration, triggering events, and when a research collaboration needs one, the other, or both together.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · included with Regulatory Radar
Ask about MTA vs. NDA: What Each One Covers
Ask CASRAI answers research-administration questions and cites the passages behind every claim — and says so when the corpus does not cover something, instead of guessing. It comes with a Regulatory Radar subscription at $29 a month, alongside the daily digest of regulatory changes and the dashboard of what changed.
150 questions a day, on this site, over the API, or inside your own tools through the CASRAI MCP server.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do Material Transfer Agreement (MTA), NDA / Confidentiality Agreement compare side by side?
The table below compares Material Transfer Agreement (MTA), NDA / Confidentiality Agreement across 9 procurement-relevant dimensions, from what it governs through who typically signs.
Side-by-side comparison
| Dimension | Material Transfer Agreement (MTA) | NDA / Confidentiality Agreement |
|---|---|---|
| What it governs | Transfer and use of a tangible research material (cell line, reagent, compound, biospecimen) | Disclosure and use of confidential information, independent of any physical material |
| Triggering event | A planned physical shipment of material between institutions | A planned conversation involving unpublished data, proprietary information, or business terms |
| Authorizes research to be performed? | Often — recipient typically uses the material for its own research, under the MTA’s restrictions | No — evaluation and discussion only |
| Typical duration | Restrictions generally run as long as the material/derivatives are retained or used; no fixed expiration in most cases | Fixed confidentiality term per disclosure, often a few years, independent of the relationship’s length |
| What’s restricted | Use, modification, ownership of derivatives (“progeny”), onward transfer, often publication-review timing | Disclosure or use of the covered information outside the stated evaluation purpose |
| IP/ownership terms | Addresses ownership of the material and inventions made using it | None — an NDA does not transfer, license, or encumber IP |
| Compliance overlays | Export control (EAR/ITAR) and Institutional Biosafety Committee review commonly apply | Export control can apply if the information itself is controlled technical data, but no biosafety review |
| Standard templates | UBMTA (via AUTM) and NIH Simple Letter Agreement for US academic-to-academic transfers | No single universal template; institution- and counterparty-specific, mutual or one-way |
| Who typically signs | The institution, via its TTO/sponsored-programs/research-contracts office — not the individual PI | Same pattern — institutional signature authority, not individual faculty |
Common questions
Common questions about Material Transfer Agreement (MTA) vs NDA / Confidentiality Agreement
Can an NDA substitute for a material transfer agreement?
+
No. An NDA protects confidential information; it does not authorize a physical transfer, address use or modification restrictions on a material, or trigger the export-control and biosafety review an MTA process typically requires.
Can a material transfer agreement substitute for an NDA?
+
Generally not, unless it’s specifically drafted to include confidentiality terms. A standard MTA is scoped to the material itself and typically doesn’t address confidentiality of the surrounding discussion.
Which is signed first, the NDA or the MTA?
+
Where both are needed, the NDA typically comes first, covering the due-diligence conversation about the material before either side commits to the transfer itself; the MTA follows once the parties agree the material will actually ship.
Does a collaboration ever need both running at the same time?
+
Yes — industry-sponsored collaborations commonly run an active NDA (protecting the sponsor’s proprietary information) alongside an active MTA (governing a material moving as part of the project) concurrently, for different reasons.
Do MTAs and NDAs expire the same way?
+
No. An NDA's confidentiality obligation is usually a fixed term measured from each disclosure. An MTA's restrictions on the material typically continue for as long as the recipient retains, uses, or has derivatives of the material, without necessarily having a comparable fixed expiration — see CASRAI's MTA process guide for how publication-review and other MTA terms are typically structured.
Who decides which document a given exchange needs?
+
At most research institutions, this determination is made by the technology transfer office, sponsored programs office, or research-contracts office — not by the individual researcher — precisely because the wrong document (or no document) can leave a gap in IP, confidentiality, or compliance coverage. Researchers planning an external exchange of either information or material should route the request through that office early rather than assuming one document covers what actually requires both.
Going deeper
